Efficacy and Safety of PR022 Topical Gel to Treat Mild-to-Moderate Atopic Dermatitis
Phase of Trial: Phase II
Latest Information Update: 15 Feb 2018
At a glance
- Drugs Hypochlorous acid (Primary)
- Indications Atopic dermatitis
- Focus Therapeutic Use
- Sponsors Realm Therapeutics
- 15 Feb 2018 According to Realm Therapeutics media release, the study is progressing as planned and top-line results are expected by the end of Q3.
- 19 Dec 2017 Status changed from not yet recruiting to recruiting.
- 16 Oct 2017 According to Realm Therapeutics media release, the Company remains on track to initiate this trial by end of the year 2017.